Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price was up 2.9% during mid-day trading on Tuesday . The stock traded as high as $37.25 and last traded at $36.38. Approximately 1,188 shares were traded during trading, a decline of 33% from the average daily volume of 1,763 shares. The stock had previously closed at $35.35.
Hikma Pharmaceuticals Trading Up 2.9%
The stock’s 50-day simple moving average is $37.03 and its 200 day simple moving average is $41.43.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Stories
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
